Here you are inform about ALS newsand the IPG actions
9th PG International Medicine Award
The Paulo Gontijo Institute (IPG) opens from May 1st to 1st July the registrations for the 9th PG International Medicine Award.
Young researchers under 40 years old and of any nationality can apply and register their projects through the site www.ipg.org.br/premioPG.
The award aims to encourage and recognize research on amyotrophic lateral sclerosis (ALS), the third most frequent neurodegenerative disease in the world. The winning research author will present the work to the scientific community and will receive the $ 20,000 prize and a gold medal awarded at the opening of the 28th International ELA / DNM Symposium to be held in Boston, United States , On next 8 December.
The Symposium is organized by the Association of Neuromuscular Diseases and the winner will present results of his work.
All expenses, including cash value, are fully covered by the Gontijo family - maintainer of the Paulo Gontijo Institute.
Donations to the IPG are fully reverted to the maintenance the Institute projects.The judgment of the PG Medical Award is made by the IPG International Jurors team, composed of scientific authorities, both Brazilian and international, involved in the research of Amyotrophic Lateral Sclerosis. The award is supported by the International Alliance of ELA / DNM, MND Association and the European Network for the Cure of ALS - (Encals) and is the only one delivered by a Brazilian entity to the international scientific community that researches the cause and cure of ALS. The judging panel will announce the winner on August 15 via the IPG website (www.ipg.org.br) and the award-winning researcher will receive a notification by email. "Over the years, the quality of work has been increasing and the most striking discoveries are recognized and disseminated. This is the most important research in ALS award and we are sure that the Paulo Gontijo Institute plays its role in promoting the highest quality research for the cure of this terrible disease ", says Prof. Dr Mamede de Carvalho, neurologist from Lisbon, Portugal, and chairman of the jury committee of the PG Prize.
Amyotrophic Lateral Sclerosis causes muscle atrophy and the patient's median survival is only three years. In Brazil, it is estimated that 12 to 15 thousand people have the disease. Worldwide, there are about 200,000.
The IPG is proud of its previous year's award participants who continue to participate in important impact projects in international research that seek the cause and cure of ALS. The PG award is also a way of recognizing IPG's creator, Paulo Gontijo, who was affected by the disease and worked tirelessly searching for his cure. About IPG
The Paulo Gontijo Institute is a private, non-profit organization (OSCIP), which acts to promote research and scientific studies that contribute to increase the level of knowledge regarding amyotrophic lateral sclerosis (ALS). In addition, its mission is to develop sensitization and humanization actions that contribute to the better care of professionals, patients and their families.
The physicist and engineer Paulo Gontijo was diagnosed as having ALS in 1999. Researcher, tirelessly sought the cause and cure of the disease and idealized the first molds of how the institution would be and what would be its contribution in favor of science.
The IPG was founded by bis children, in 2005, three years after his death.